149 related articles for article (PubMed ID: 11357223)
1. Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease.
Georgi M; Scheckenbach C; Kromminga A; Partscht K; Messer G; Bröcker EB; Zillikens D
Arch Dermatol Res; 2001 Mar; 293(3):109-14. PubMed ID: 11357223
[TBL] [Abstract][Full Text] [Related]
2. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
[TBL] [Abstract][Full Text] [Related]
3. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
4. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.
Schumann H; Baetge J; Tasanen K; Wojnarowska F; Schäcke H; Zillikens D; Bruckner-Tuderman L
Am J Pathol; 2000 Feb; 156(2):685-95. PubMed ID: 10666397
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
[TBL] [Abstract][Full Text] [Related]
6. Major cleavage-dependent epitopes for linear IgA bullous dermatosis are formed at the boundary between the non-collagenous 16A and collagenous 15 domains of BP180.
Yamauchi T; Matsushita S; Hashimoto T; Hirako Y
J Dermatol Sci; 2014 Oct; 76(1):25-33. PubMed ID: 25176590
[TBL] [Abstract][Full Text] [Related]
7. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
[TBL] [Abstract][Full Text] [Related]
8. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.
Zillikens D
Keio J Med; 2002 Mar; 51(1):21-8. PubMed ID: 11951375
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans.
Olivry T; Dunston SM; Fahey M; Nguyen N; Marinkovich MP
Vet Pathol; 2000 Jul; 37(4):302-9. PubMed ID: 10896391
[TBL] [Abstract][Full Text] [Related]
10. Cicatricial pemphigoid with circulating IgA and IgG autoantibodies to the central portion of the BP180 ectodomain: beneficial effect of adjuvant therapy with high-dose intravenous immunoglobulin.
Leverkus M; Georgi M; Nie Z; Hashimoto T; Bröcker EB; Zillikens D
J Am Acad Dermatol; 2002 Jan; 46(1):116-22. PubMed ID: 11756957
[TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida.
Bédane C; McMillan JR; Balding SD; Bernard P; Prost C; Bonnetblanc JM; Diaz LA; Eady RA; Giudice GJ
J Invest Dermatol; 1997 Jun; 108(6):901-7. PubMed ID: 9182819
[TBL] [Abstract][Full Text] [Related]
12. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
[TBL] [Abstract][Full Text] [Related]
13. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid.
Fairley JA; Fu CL; Giudice GJ
J Invest Dermatol; 2005 Sep; 125(3):467-72. PubMed ID: 16117787
[TBL] [Abstract][Full Text] [Related]
14. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
15. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.
Kromminga A; Sitaru C; Meyer J; Arndt R; Schmidt E; Christophers E; Bröcker EB; Zillikens D
J Dermatol Sci; 2002 Jan; 28(1):68-75. PubMed ID: 11916132
[TBL] [Abstract][Full Text] [Related]
16. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype.
Metz BJ; Ruggeri SY; Hsu S; Reed JA; Ghohestani AS; Uitto J; Ghohestani RF
Int J Dermatol; 2004 Jun; 43(6):443-6. PubMed ID: 15186228
[TBL] [Abstract][Full Text] [Related]
17. IgE autoantibodies against the intracellular domain of BP180.
Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
[TBL] [Abstract][Full Text] [Related]
18. Linear IgA disease: the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults.
Allen J; Wojnarowska F
Br J Dermatol; 2003 Nov; 149(5):977-85. PubMed ID: 14632802
[TBL] [Abstract][Full Text] [Related]
19. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
Allen J; Shears E; Powell J; Wojnarowska F
Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]